Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in China.

Zekun LiGuoqing LiuWanru YaoZhenping ChenGang LiXiaoling ChengYingzi ZhenDi Ai Huang Kun Jie Sun Man-Chiu Poon Runhui Wu

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)

Inhibitor eradication could be achieved by low-dose ITI protocol using PCC combined with IS. Larger studies are needed to confirm if ITI with IS Regimen-2 is more effective with less complications.

Keyphrases

low dose
high dose
helicobacter pylori infection
randomized controlled trial
young adults
diffuse large b cell lymphoma
risk factors
hodgkin lymphoma